Safety and Efficacy of Defocus Distributed Multi-point Lens in Myopia Control

NCT05340699 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2022-12-07

No results posted yet for this study

Summary

Evaluate the safety and effectiveness of experimental group by comparing with the control group

Conditions

  • Myopia

Interventions

DEVICE

Defocus Distributed Multi-point lens

Wear DDM lens

DEVICE

Single vision lens

Wear single vision lens

Sponsors & Collaborators

  • Tianjin Eye Hospital

    lead OTHER

Principal Investigators

  • Xiaoqin Chen, MD · Tianjin Eye Hospital, Tianjin,China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-02-20
Completion
2023-05-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05340699 on ClinicalTrials.gov